Top 5 theatre shows to see this week (October 15-21)
The Inheritance – Noel Coward Theatre, London
Matthew Lopez’s ambitious and moving seven- hour, two-part update of EM Forster’s Howards End, exploring the legacy of the Aids crisis among a generation of young gay New Yorkers, transfers to the West End. Stephen Daldry’s production opens on October 13.
Death of a Salesman – Royal Exchange Theatre, Manchester
Following his towering performance as Lear, Don Warrington returns to the Royal Exchange to play Willy Loman opposite Maureen Beattie as Mrs Loman in Sarah Frankcom’s production of Arthur Miller’s classic. It opens in Manchester on October 16.
Don Carlos – Northcott Theatre, Exeter
Tom Burke, star of Strike, will take on Schiller’s Don Carlos in the first production from his new company Ara, co-founded with director Gadi Roll. It opens at Exeter’s Northcott on October 16.
Company – Gielgud Theatre, London
This one’s going to be immense. Marianne Elliott directs a gender-switched revival of one of Stephen Sondheim’s best works. Rosalie Craig plays the lead in a cast that also features Jonathan Bailey, Mel Giedroyc and Patti LuPone. It opens in the West End on October 17.
Wise Children – Old Vic, London
Emma Rice directed a brilliant version of Angela Carter’s Nights of the Circus back in 2006. Now she turns her attention to Carter’s final novel, a delicious collision of Shakespeare and music hall, in a production that opens at the Old Vic on October 17 ahead of a UK tour.
We need your help…
When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.
The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.
We are fully independent, but this means we rely on revenue from readers to survive.
Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.